Showing 1 - 8 results of 8 for search 'Kevin K Ariën', query time: 0.04s Refine Results
  1. 1
    Can Zika virus antibodies cross-protect against dengue virus?

    Can Zika virus antibodies cross-protect against dengue virus? by Kevin K Ariën, Johan Michiels, Nikki Foqué, Leo Heyndrickx, Marjan Van Esbroeck

    Published 2018
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms.

    The prior infection with SARS-CoV-2 study (PICOV) in nursing home residents and staff - study protocol description and presentation of preliminary findings on symptoms. by Maria E. Goossens, Kristof Y. Neven, Pieter Pannus, Cyril Barbezange, Isabelle Thomas, Steven Van Gucht, Katelijne Dierick, Marie-Noëlle Schmickler, Mathieu Verbrugghe, Nele Van Loon, Kevin K Ariën, Arnaud Marchant, Stanislas Goriely, Isabelle Desombere

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Dengue and chikungunya among outpatients with acute undifferentiated fever in Kinshasa, Democratic Republic of Congo: A cross-sectional study.

    Dengue and chikungunya among outpatients with acute undifferentiated fever in Kinshasa, Democratic Republic of Congo: A cross-sectional study. by Sam Proesmans, Freddy Katshongo, John Milambu, Blaise Fungula, Hypolite Muhindo Mavoko, Steve Ahuka-Mundeke, Raquel Inocêncio da Luz, Marjan Van Esbroeck, Kevin K Ariën, Lieselotte Cnops, Birgit De Smet, Pascal Lutumba, Jean-Pierre Van Geertruyden, Veerle Vanlerberghe

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    Multiplex detection of antibodies to Chikungunya, O'nyong-nyong, Zika, Dengue, West Nile and Usutu viruses in diverse non-human primate species from Cameroon and the Democratic Republic of Congo.

    Multiplex detection of antibodies to Chikungunya, O'nyong-nyong, Zika, Dengue, West Nile and Usutu viruses in diverse non-human primate species from Cameroon and the Democratic Rep... by Raisa Raulino, Guillaume Thaurignac, Christelle Butel, Christian Julian Villabona-Arenas, Thomas Foe, Severin Loul, Simon-Pierre, Placide Mbala-Kingebeni, Sheila Makiala-Mandanda, Steve Ahuka-Mundeke, Karen Kerkhof, Eric Delaporte, Kevin K Ariën, Vincent Foulongne, Eitel Mpoudi Ngole, Martine Peeters, Ahidjo Ayouba

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    COVID-19 seroprevalence cohort survey among health care workers and their household members in Kinshasa, DR Congo, 2020-2022

    COVID-19 seroprevalence cohort survey among health care workers and their household members in Kinshasa, DR Congo, 2020-2022 by Joule Madinga, Placide Mbala-Kingebeni, Antoine Nkuba-Ndaye, Leonel Baketana-Kinzonzi, Elysé Matungulu-Biyala, Patrick Mutombo-Lupola, Caroline-Aurore Seghers, Tom Smekens, Kevin K. Ariën, Wim Van Damme, Andreas Kalk, Martine Peeters, Steve Ahuka-Mundeke, Jean-Jacques M, Veerle Vanlerberghe

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial.

    Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial. by Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Sarah Houben, Kristof Y Neven, Leo Heyndrickx, Johan Michiels, Elisabeth Willems, Stéphane De Craeye, Antoine Francotte, Félicie Chaumont, Véronique Olislagers, Alexandra Waegemans, Mathieu Verbrugghe, Marie-Noëlle Schmickler, Steven Van Gucht, Katelijne Dierick, Arnaud Marchant, Isabelle Desombere, Kevin K Ariën, Maria E Goossens

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial

    Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial by Pieter Pannus, Stéphanie Depickère, Delphine Kemlin, Sarah Houben, Kristof Y. Neven, Leo Heyndrickx, Johan Michiels, Elisabeth Willems, Stéphane De Craeye, Antoine Francotte, Félicie Chaumont, Véronique Olislagers, Alexandra Waegemans, Mathieu Verbrugghe, Marie-Noëlle Schmickler, Steven Van Gucht, Katelijne Dierick, Arnaud Marchant, Isabelle Desombere, Kevin K. Ariën, Maria E. Goossens

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas

    ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas by Annelies Wilder-Smith, Raman Preet, Elizabeth B. Brickley, Ricardo Arraes de Alencar Ximenes, Demócrito de Barros Miranda-Filho, Celina Maria Turchi Martelli, Thália Velho Barreto de Araújo, Ulisses Ramos Montarroyos, Maria Elisabeth Moreira, Marília Dalva Turchi, Tom Solomon, Bart C. Jacobs, Carlos Pardo Villamizar, Lyda Osorio, Ana Maria Bispo de Filipps, Johan Neyts, Suzanne Kaptein, Ralph Huits, Kevin K. Ariën, Hugh J. Willison, Julia M. Edgar, Susan C. Barnett, Rosanna Peeling, Debi Boeras, Maria G. Guzman, Aravinda M. de Silva, Andrew K. Falconar, Claudia Romero-Vivas, Michael W. Gaunt, Alessandro Sette, Daniela Weiskopf, Louis Lambrechts, Helen Dolk, Joan K. Morris, Ieda M. Orioli, Kathleen M. O'Reilly, Laith Yakob, Joacim Rocklöv, Cristiane Soares, Maria Lúcia Brito Ferreira, Rafael Freitas de Oliveira Franca, Alexander R. Precioso, James Logan, Trudie Lang, Nina Jamieson, Eduardo Massad

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: